-
1
-
-
0003224009
-
A minute chromosome (Phl) in human chronic granulocytic leukemia
-
Nowell P.C. A minute chromosome (Phl) in human chronic granulocytic leukemia. Blut. 8:1962;65-66
-
(1962)
Blut
, vol.8
, pp. 65-66
-
-
Nowell, P.C.1
-
2
-
-
0015694748
-
A new consistent chromosomal abnormality in chronic myeloid leukemia identified by quinacrine fluorescence and Giemsa staining [letter]
-
Rowley J.D. A new consistent chromosomal abnormality in chronic myeloid leukemia identified by quinacrine fluorescence and Giemsa staining [letter]. Nature. 243:1973;290-293
-
(1973)
Nature
, vol.243
, pp. 290-293
-
-
Rowley, J.D.1
-
3
-
-
0025854383
-
Interferon-alpha produces sustained cytogenetic responses in chronic myelogenous leukemia. Philadelphia chromosome-positive patients
-
Talpaz M., Kantarjian H., Kurzrock R., et al. Interferon-alpha produces sustained cytogenetic responses in chronic myelogenous leukemia. Philadelphia chromosome-positive patients. Ann Intern Med. 114:1991;532-538
-
(1991)
Ann Intern Med
, vol.114
, pp. 532-538
-
-
Talpaz, M.1
Kantarjian, H.2
Kurzrock, R.3
-
4
-
-
0035810147
-
Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia
-
Druker B.J., Talpaz M., Resta D.J., et al. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N Engl J Med. 344:2001;1031-1037
-
(2001)
N Engl J Med
, vol.344
, pp. 1031-1037
-
-
Druker, B.J.1
Talpaz, M.2
Resta, D.J.3
-
5
-
-
0029952614
-
Allogeneic bone marrow transplantation for CML: A report from the International Bone Marrow Registry
-
Horowitz M.M., Rowlings P.A., Passweg J.R. Allogeneic bone marrow transplantation for CML: a report from the International Bone Marrow Registry. Bone Marrow Transplant. 17:1996;S5-S6
-
(1996)
Bone Marrow Transplant
, vol.17
, pp. 5-S6
-
-
Horowitz, M.M.1
Rowlings, P.A.2
Passweg, J.R.3
-
6
-
-
0027519484
-
Bone marrow transplantation for chronic myeloid leukemia: Long-term results. Chronic Leukemia Working Party of the European Group for Bone Marrow Transplantation
-
Gratwohl A., Hermans J., Niederwieser D., et al. Bone marrow transplantation for chronic myeloid leukemia: long-term results. Chronic Leukemia Working Party of the European Group for Bone Marrow Transplantation. Bone Marrow Transplant. 12:1993;509-516
-
(1993)
Bone Marrow Transplant
, vol.12
, pp. 509-516
-
-
Gratwohl, A.1
Hermans, J.2
Niederwieser, D.3
-
7
-
-
0030003140
-
Marrow transplantation for CML: The Seattle experience
-
Clift R.A., Storb R. Marrow transplantation for CML: the Seattle experience. Bone Marrow Transplant. 17:1996;S1-S3
-
(1996)
Bone Marrow Transplant
, vol.17
, pp. 1-S3
-
-
Clift, R.A.1
Storb, R.2
-
8
-
-
0027504087
-
Graft-versus-leukemia: No longer an epiphenomenon
-
Antin J.H. Graft-versus-leukemia: no longer an epiphenomenon. Blood. 82:1993;2273-2277
-
(1993)
Blood
, vol.82
, pp. 2273-2277
-
-
Antin, J.H.1
-
9
-
-
0019861205
-
Antileukemic effect of chronic graft-versus-host disease: Contribution to improved survival after allogeneic marrow transplantation
-
Weiden P.L., Sullivan K.M., Flournoy N., et al. Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation. N Engl J Med. 304:1981;1529-1533
-
(1981)
N Engl J Med
, vol.304
, pp. 1529-1533
-
-
Weiden, P.L.1
Sullivan, K.M.2
Flournoy, N.3
-
10
-
-
0023690307
-
Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion
-
Goldman J.M., Gale R.P., Horowitz M.M., et al. Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion. Ann Intern Med. 108:1988;806-814
-
(1988)
Ann Intern Med
, vol.108
, pp. 806-814
-
-
Goldman, J.M.1
Gale, R.P.2
Horowitz, M.M.3
-
11
-
-
0027437385
-
Salvage immunotherapy using donor leukocyte infusions as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation: Efficacy and toxicity of a defined T-cell dose
-
Drobyski W.R., Keever C.A., Roth M.S., et al. Salvage immunotherapy using donor leukocyte infusions as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation: efficacy and toxicity of a defined T-cell dose. Blood. 82:1993;2310-2318
-
(1993)
Blood
, vol.82
, pp. 2310-2318
-
-
Drobyski, W.R.1
Keever, C.A.2
Roth, M.S.3
-
12
-
-
0028237517
-
Relapse of chronic myeloid leukemia after allogeneic bone marrow transplant: The case for giving donor leukocyte transfusions before the onset of hematologic relapse
-
van Rhee F., Lin F., Cullis J.O., et al. Relapse of chronic myeloid leukemia after allogeneic bone marrow transplant: the case for giving donor leukocyte transfusions before the onset of hematologic relapse. Blood. 83:1994;3377-3383
-
(1994)
Blood
, vol.83
, pp. 3377-3383
-
-
Van Rhee, F.1
Lin, F.2
Cullis, J.O.3
-
13
-
-
0025678601
-
Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients
-
Kolb H.J., Mittermuller J., Clemm C., et al. Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood. 76:1990;2462-2465
-
(1990)
Blood
, vol.76
, pp. 2462-2465
-
-
Kolb, H.J.1
Mittermuller, J.2
Clemm, C.3
-
14
-
-
0029618806
-
Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor peripheral blood lymphocytes
-
Slavin S., Naparstek E., Nagler A., et al. Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor peripheral blood lymphocytes. Exp Hematol. 23:1995;1553-1562
-
(1995)
Exp Hematol
, vol.23
, pp. 1553-1562
-
-
Slavin, S.1
Naparstek, E.2
Nagler, A.3
-
15
-
-
0028871935
-
CD8-depleted donor lymphocyte infusion as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation
-
Giralt S., Hester J., Huh Y., et al. CD8-depleted donor lymphocyte infusion as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation. Blood. 86:1995;4337-4343
-
(1995)
Blood
, vol.86
, pp. 4337-4343
-
-
Giralt, S.1
Hester, J.2
Huh, Y.3
-
16
-
-
0017166432
-
Long term survival of skin allografts in mice treated with fractionated total lymphoid irradiation
-
Slavin S., Strober S., Fuks Z., et al. Long term survival of skin allografts in mice treated with fractionated total lymphoid irradiation. Science. 193:1976;1252-1254
-
(1976)
Science
, vol.193
, pp. 1252-1254
-
-
Slavin, S.1
Strober, S.2
Fuks, Z.3
-
17
-
-
0028858133
-
DLA-identical bone marrow grafts after low-dose total body irradiation: Effects of high-dose corticosteroids and cyclosporine on engraftment
-
Yu C., Storb R., Mathey B., et al. DLA-identical bone marrow grafts after low-dose total body irradiation: effects of high-dose corticosteroids and cyclosporine on engraftment. Blood. 86:1995;4376-4381
-
(1995)
Blood
, vol.86
, pp. 4376-4381
-
-
Yu, C.1
Storb, R.2
Mathey, B.3
-
18
-
-
0034657267
-
Adoptive immunotherapy in canine mixed chimeras after non-myeloablative hematopoietic cell transplantation
-
Georges G.E., Storb R., Thompson J.D., et al. Adoptive immunotherapy in canine mixed chimeras after non-myeloablative hematopoietic cell transplantation. Blood. 95:2000;3262-3269
-
(2000)
Blood
, vol.95
, pp. 3262-3269
-
-
Georges, G.E.1
Storb, R.2
Thompson, J.D.3
-
20
-
-
0030925301
-
Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: Harnessing graft-versus-leukemia without myeloablative therapy
-
Giralt S., Estey E., Albitar M., et al. Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy. Blood. 89:1997;4531-4536
-
(1997)
Blood
, vol.89
, pp. 4531-4536
-
-
Giralt, S.1
Estey, E.2
Albitar, M.3
-
21
-
-
0000271327
-
Comparisons of donor chimerism, graft rejection, and GVHD after hematopoietic stem cell transplants (HSCT) from HLA matched siblings and unrelated donors using conditioning with 2 Gy TBI with and without fludarabine [abstract]
-
Maris M.B., Sandmeier B.M., Niederwieser D., et al. Comparisons of donor chimerism, graft rejection, and GVHD after hematopoietic stem cell transplants (HSCT) from HLA matched siblings and unrelated donors using conditioning with 2 Gy TBI with and without fludarabine [abstract]. Blood. 96(1):2000;520a
-
(2000)
Blood
, vol.96
, Issue.1
-
-
Maris, M.B.1
Sandmeier, B.M.2
Niederwieser, D.3
-
22
-
-
0033642531
-
Intentional induction of mixed chimerism and achievement of antitumor responses after nonmyeloablative conditioning therapy and HLA-matched donor bone marrow transplantation for refractory hematologic malignancies
-
Spitzer T.R., McAfee S., Sackstein R., et al. Intentional induction of mixed chimerism and achievement of antitumor responses after nonmyeloablative conditioning therapy and HLA-matched donor bone marrow transplantation for refractory hematologic malignancies. Biol Blood Marrow Transplant. 6(3A):2000;309-320
-
(2000)
Biol Blood Marrow Transplant
, vol.6
, Issue.3 A
, pp. 309-320
-
-
Spitzer, T.R.1
McAfee, S.2
Sackstein, R.3
-
23
-
-
12244280160
-
FLAG-IDA, a non-ablative preparative regimen, with allogeneic PBSC transplantation for CML [abstract]
-
Champlin R.E., Shimoni A., Cohen A., et al. FLAG-IDA, a non-ablative preparative regimen, with allogeneic PBSC transplantation for CML [abstract]. Blood. 96(Suppl 1):2000;410a
-
(2000)
Blood
, vol.96
, Issue.SUPPL. 1
-
-
Champlin, R.E.1
Shimoni, A.2
Cohen, A.3
-
24
-
-
0035254219
-
Melphalan and purine analog-containing preparative regimens: Reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation
-
Giralt S., Thall P.F., Khouri I., et al. Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation. Blood. 97:2001;631-637
-
(2001)
Blood
, vol.97
, pp. 631-637
-
-
Giralt, S.1
Thall, P.F.2
Khouri, I.3
-
25
-
-
0037438397
-
Nonmyeloablative allogeneic stem cell transplantation for the treatment of chronic myeloid leukemia in first chronic phase
-
Or R., Shapira M.Y., Resnick I., et al. Nonmyeloablative allogeneic stem cell transplantation for the treatment of chronic myeloid leukemia in first chronic phase. Blood. 101(2):2003;441-445
-
(2003)
Blood
, vol.101
, Issue.2
, pp. 441-445
-
-
Or, R.1
Shapira, M.Y.2
Resnick, I.3
-
26
-
-
85112360893
-
Induction of molecular remissions in CML with non-myeloablative HLA-identical sibling allografts [abstract]
-
Sandmaier B.M., Niederwieser D., McSweeney P.A., et al. Induction of molecular remissions in CML with non-myeloablative HLA-identical sibling allografts [abstract]. Blood. 96(Suppl 1):2000;201a
-
(2000)
Blood
, vol.96
, Issue.SUPPL. 1
-
-
Sandmaier, B.M.1
Niederwieser, D.2
McSweeney, P.A.3
-
27
-
-
0003277746
-
Non-myeloablative peripheral blood stem cell transplantation for chronic myelogenous leukemia
-
Sloand E.M., Childs R.W., Greene A., et al. Non-myeloablative peripheral blood stem cell transplantation for chronic myelogenous leukemia. [abstract]. Blood. 96(Suppl 1):2000;783a
-
(2000)
Blood
, vol.96
, Issue.SUPPL. 1
-
-
Sloand, E.M.1
Childs, R.W.2
Greene, A.3
-
28
-
-
0034772639
-
Dose-reduced conditioning for allografting in 44 patients with chronic myeloid leukaemia: A retrospective analysis
-
Bornhauser M., Kiehl M., Siegert W., et al. Cooperative German Transplant Study Group Dose-reduced conditioning for allografting in 44 patients with chronic myeloid leukaemia: a retrospective analysis. Br J Haematol. 115(1):2001;119-124
-
(2001)
Br J Haematol
, vol.115
, Issue.1
, pp. 119-124
-
-
Bornhauser, M.1
Kiehl, M.2
Et Al., S.W.3
-
29
-
-
12244289841
-
Favorable outcome of non-myeloablative stem cell transplant for CML in first chronic phase; A retrospective study of the European Group for Blood and Marrow Transplantation (EBMT) [abstract]
-
Lalancette M., Rezvani K., Szydlo R., et al. Favorable outcome of non-myeloablative stem cell transplant for CML in first chronic phase; a retrospective study of the European Group for Blood and Marrow Transplantation (EBMT) [abstract]. Blood. 96(Suppl 1):2000;2340a
-
(2000)
Blood
, vol.96
, Issue.SUPPL. 1
-
-
Lalancette, M.1
Rezvani, K.2
Szydlo, R.3
-
30
-
-
0025963233
-
Graft-versus-host disease
-
Ferrara J.L., Deeg H.J. Graft-versus-host disease. N Engl J Med. 324:1991;667-674
-
(1991)
N Engl J Med
, vol.324
, pp. 667-674
-
-
Ferrara, J.L.1
Deeg, H.J.2
-
31
-
-
0030817818
-
Transfusion-associated graft-versus-host disease
-
Orlin J.B., Ellis M.H. Transfusion-associated graft-versus-host disease. Curr Opin Hemato. 14:1997;442-448
-
(1997)
Curr Opin Hemato
, vol.14
, pp. 442-448
-
-
Orlin, J.B.1
Ellis, M.H.2
-
32
-
-
4244017667
-
Graft versus host disease after non-myeloablative versus myeloablative conditioning regimens in fully matched sibling donor hematopoietic stem cell transplants [abstract]
-
Couriel D., Giralt S., de Lima M., et al. Graft versus host disease after non-myeloablative versus myeloablative conditioning regimens in fully matched sibling donor hematopoietic stem cell transplants [abstract]. Blood. 96(Suppl 1):2000;408a
-
(2000)
Blood
, vol.96
, Issue.SUPPL. 1
-
-
Couriel, D.1
Giralt, S.2
De Lima, M.3
-
33
-
-
0000271328
-
Older patient age remains a risk factor for transplant related mortality following nonmyeloablative allogeneic stem cell transplantation [abstract]
-
Childs R.W., Bahceci E., Eniafe R., et al. Older patient age remains a risk factor for transplant related mortality following nonmyeloablative allogeneic stem cell transplantation [abstract]. Blood. 96(Suppl 1):2000;520a
-
(2000)
Blood
, vol.96
, Issue.SUPPL. 1
-
-
Childs, R.W.1
Bahceci, E.2
Eniafe, R.3
-
34
-
-
85047690151
-
Factors associated with graft rejection after HLA-identical marrow transplantation for aplastic anaemia
-
Storb R., Prentice R.L., Thomas E.D., et al. Factors associated with graft rejection after HLA-identical marrow transplantation for aplastic anaemia. Br J Haematol. 55:1983;573-585
-
(1983)
Br J Haematol
, vol.55
, pp. 573-585
-
-
Storb, R.1
Prentice, R.L.2
Thomas, E.D.3
-
35
-
-
0002042474
-
Non-myeloablative stem cell transplantation: Lessons from the first generation trials
-
Giralt S. Non-myeloablative stem cell transplantation: lessons from the first generation trials. Leuk Lymphoma Updates. 2:1999;4-7
-
(1999)
Leuk Lymphoma Updates
, vol.2
, pp. 4-7
-
-
Giralt, S.1
-
36
-
-
0025852066
-
Are new conditioning regimens for transplants in acute myelogenous leukemia better?
-
Aurer I., Gale R.P. Are new conditioning regimens for transplants in acute myelogenous leukemia better? Bone Marrow Transplant. 7:1991;255-261
-
(1991)
Bone Marrow Transplant
, vol.7
, pp. 255-261
-
-
Aurer, I.1
Gale, R.P.2
|